ImmunXperts, a Q² Solutions Company ImmunXperts, a Q² Solutions Company

Menu
  • Home
  • Services
    • Immunogenicity
    • Immuno-Oncology
    • Cell Therapy
    • ImmunAcademy
  • About Us
    • Team
    • Scientific Advisory Board
  • News & Events
  • Contact Us
  • Careers

You are here:

  1. Home
  2. News & Events
  3. Advances in Immuno-oncology Congress 2016

Advances in Immuno-oncology Congress 2016

12 May 2016

We are presenting a poster on In Vitro Functional Assays for Immune Checkpoint Screening at the Oxford Global Advances in Immuno-oncology Congress in London, May 12- 13th.

http://www.immunooncology-congress.com/

Posted in:
  • Events

See more

  1. Prev:PEGS Boston 2016
  2. Back: All Posts
  3. Next:SMi Immunogenicity 2016 & Workshop

Recent Posts

  • In vitro Immunogenicity and Functional Testing of Nanoparticles, mRNA, and Biologics
  • Happy to join the Nexelis family
  • 11th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
  • Innovation for Health
  • PEGS Europe, 18-22 November 2019, Lisbon

Categories

  • Events
  • News
  • Uncategorized
 
  • linkedin
  • twitter

Services

  • Immunogenicity
  • Immuno-Oncology
  • Cell Therapy
  • ImmunAcademy

About Us

  • Team
  • Scientific Advisory Board

News & Events

  • News
  • Events
Website by Uchrony
  • Home
  • Contact Us
  • Careers

© ImmunXperts, a Q² Solutions Company | Rue Auguste Piccard 48 6041 Gosselies | +32(0)71960133


Contact Us
Q² Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions.
Learn more at www.q2labsolutions.com.

Back to Top